[Tenth International Symposium on Amyloid and Amyloidosis].
Magy
N
N
Service de médecine interne et immunologie clinique, CHU Jean-Minjoz, 2, boulevard Fleming, 25000 Besançon, France.
Grateau
G
G
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000682:Amyloid; D000686:Amyloidosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy; D000818:Animals; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic; D015331:Cohort Studies; D003937:Diagnosis, Differential; D004195:Disease Models, Animal; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008558:Melphalan / Q000008:administration & dosage / Q000627:therapeutic use; D051379:Mice; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D000685:Serum Amyloid A Protein; D033581:Stem Cell Transplantation; D014182:Transplantation, Autologous
D000682:Amyloid; D018906:Antineoplastic Agents, Alkylating; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D000685:Serum Amyloid A Protein; D000068800:Etanercept; D008558:Melphalan